AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $428,000 | -37.7% | 85,000 | 0.0% | 0.00% | -42.9% |
| Q2 2020 | $687,000 | +329.4% | 85,000 | +37.1% | 0.01% | +250.0% |
| Q4 2018 | $160,000 | -41.2% | 62,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $272,000 | -28.4% | 62,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $380,000 | -15.9% | 62,000 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $452,000 | -11.0% | 62,000 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $508,000 | -56.4% | 62,000 | -44.1% | 0.01% | -55.0% |
| Q3 2017 | $1,166,000 | -4.7% | 111,000 | 0.0% | 0.02% | -13.0% |
| Q2 2017 | $1,224,000 | +13.9% | 111,000 | 0.0% | 0.02% | +9.5% |
| Q1 2017 | $1,075,000 | – | 111,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |